We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Cryoablation Found Effective for Atrial Flutter

By HospiMedica staff writers
Posted on 26 Nov 2003
Studies conducted by Italian researchers have shown a success rate of 90-100% when treating typical atrial flutter with cryoablation. More...
The abstracts were presented at the annual International Workshop on Arrhythmias in Venice (Italy).

Of 143 patients, 130 had atrial flutter, of whom 103 were treated with the Freezor Xtra and 27 with the Freezor Max ablation catheters of CryoCath Technologies, Inc. (Montreal, Canada). The results showed the Xtra had an acute success rate of 90%, on a par with radiofrequency (RF) ablation results. The study center was able to improve the success rate to 100% with Max. CryoCath states that by providing the optimal amount of refrigerant over a larger tip, Freezor Max allows doctors to make larger, deeper lesions. It is better suited to treat arrhythmias such as atrial flutter and prevalent left-sided arrhythmias, the company notes, where a more powerful lesion-making catheter is required for anatomical reasons.

"Our center has now performed a total of 31 flutter ablation cases using Freezor Max with a 100% acute success rate,” said Dr. A.S. Montenero of the Policlinico MultiMedica (Milan, Italy). "Our overall success rate with cryoablation is similar to RF ablation, but with the advent of Freezor Max, it's now trending much higher.”




Related Links:
Cryocath

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
X-Ray System
Leonardo DR mini III
Premium Air-Mattress
MA-51
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.